EDGAR Filing Documents for 0001127602-24-002017

Form 4 - Statement of changes in beneficial ownership of securities:

SEC Accession No. 0001127602-24-002017

Filing Date

2024-01-24

Accepted

2024-01-24 16:06:20

Documents

Period of Report

2024-01-23

Document Format Files

Seq	Description	Document	Type	Size
1	PRIMARY DOCUMENT	form4.html	4
1	PRIMARY DOCUMENT	form4.xml	4	3048
	Complete submission text file	0001127602-24-002017.txt		4472

Mailing Address 100 FIFTH AVENUE WALTHAM MA 02451

Business Address 100 FIFTH AVENUE WALTHAM MA 02451 617-977-5700

Apellis Pharmaceuticals, Inc. (Issuer) CIK: 0001492422 (see all company filings)

IRS No.: 271537290 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address APELLIS PHARMACEUTICALS, INC. 100 5TH AVENUE, 3RD FLOOR WALTHAM MA 02451

Business Address

Type: 4 | Act: 34 | File No.: 001-38276 | Film No.: 24556459